Summary of recommendations for the design of clinical trials and the registration of drugs used in the treatment of asthma

scientific article published on June 2004

Summary of recommendations for the design of clinical trials and the registration of drugs used in the treatment of asthma is …
instance of (P31):
review articleQ7318358
scholarly articleQ13442814

External links are
P356DOI10.1016/J.RMED.2003.12.005
P698PubMed publication ID15191031
P5875ResearchGate publication ID8516370

P50authorStephen T. HolgateQ1547900
Hans BisgaardQ37615680
Leonardo M. FabbriQ42745775
P2093author name stringM Doherty
J Bousquet
M D'Amato
R Pauwels
K F Chung
J Y Reginster
K Rabe
F Cuss
Group for the Respect of Ethics and Excellence in Science: Asthma section
N J C Snell
P433issue6
P921main subjectasthmaQ35869
P304page(s)479-487
P577publication date2004-06-01
P1433published inRespiratory MedicineQ2659932
P1476titleSummary of recommendations for the design of clinical trials and the registration of drugs used in the treatment of asthma
P478volume98

Reverse relations

cites work (P2860)
Q64096294Clinical efficacy and safety of anticholinergic therapies in pediatric patients
Q64096289Future perspectives of anticholinergics for the treatment of asthma in adults and children
Q26783200Recommendations and evidence for reporting items in pediatric clinical trial protocols and reports: two systematic reviews
Q37711245The need for a transparent, ethical, and successful relationship between academic scientists and the pharmaceutical industry: a view of the Group for the Respect of Ethics and Excellence in Science (GREES).

Search more.